Changeflow GovPing Trade & Sanctions UKHSA VZIG 2025 Contract Modification with Grifols
Routine Notice Amended Final

UKHSA VZIG 2025 Contract Modification with Grifols

Favicon for www.find-tender.service.gov.uk Find a Tender - Latest Notices
Published
Detected
Email

Summary

UK Health Security Agency (UKHSA) has issued a contract modification notice for VZIG (Varicella-zoster immunoglobulin) 2025 with Grifols UK Limited, extending the contract through 30 April 2027. The modification authorises an increase in product volume under the existing contractual flexibility provisions. The total contract value remains at £1 excluding VAT, and the contract may be made available to UK devolved administrations, Crown Dependencies and British Overseas Territories for their immunisation programmes.

“The Authority is invoking the contractual flexibility provisions to authorise an increase in the product volume.”

UKHSA , verbatim from source
Published by UKHSA on find-tender.service.gov.uk . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors Find a Tender - Latest Notices for new trade & sanctions regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 1,065 changes logged to date.

What changed

UKHSA has modified Contract C352339 for varicella-zoster immunoglobulin (VZIG) with Grifols UK Limited to authorise an increase in product volume under the original contract terms. The modification was processed under the contractual flexibility provisions, and the contract end date (30 April 2027) and total value (£1 excluding VAT) remain unchanged. The contract originally ran from 1 May 2025 to 30 April 2027 and was awarded to Grifols UK Limited on 26 February 2025.

The modification is administrative in nature and does not alter the existing contractual framework or require a new procurement exercise. Affected NHS bodies and devolved administrations that rely on UKHSA procurement for VZIG supply should note the volume increase, but no new compliance obligations arise from this modification notice.

Archived snapshot

Apr 22, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Contract

Varicella-zoster immunoglobulin (VZIG) 2025

  • Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency F20: Modification notice

Notice identifier: 2026/S 000-036821

Procurement identifier (OCID): ocds-h6vhtk-047b9e

Published 22 April 2026, 4:58pm

Watch this notice

Contents

one. Contracting authority/entity Press escape key to exit two. Object four. Procedure five. Award of contract/concession six. Complementary information seven. Modifications to the contract/concession

Download

Share this notice

-

- Email

Print this notice Report concerns about this procurement

Section one: Contracting authority/entity

one.1) Name and addresses

Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

10 South Colonnade

London

E14 4PU

Email

commercial.preparednessandcountermeasures@ukhsa.gov.uk

Country

United Kingdom

NUTS code

UKI42 - Tower Hamlets

Internet address(es)

Main address

https://www.gov.uk/government/organisations/uk-health-security-agency

Buyer's address

https://www.gov.uk/government/organisations/uk-health-security-agency

Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Varicella-zoster immunoglobulin (VZIG) 2025

two.1.2) Main CPV code

Immune sera and immunoglobulins

two.1.3) Type of contract

Supplies

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UK - United Kingdom

two.2.4) Description of the procurement at the time of conclusion of the contract:

Contract for the provision of Varicella-zoster immunoglobulin

two.2.7) Duration of the contract, framework agreement, dynamic purchasing system or concession

Start date

1 May 2025

End date

30 April 2027

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section four. Procedure

four.2) Administrative information

four.2.1) Contract award notice concerning this contract

Notice number: 2025/S 000-009988

Section five. Award of contract/concession

Contract No

C352339

Lot No

1

five.2) Award of contract/concession

five.2.1) Date of conclusion of the contract/concession award decision:

26 February 2025

five.2.2) Information about tenders

The contract/concession has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor/concessionaire

Grifols UK Limited

3980 - 3990 Enterprise Cambridge Research Park Beach Drive Waterbeach Cambridgeshire

Cambridge

CB25 9PE

Email

christopher.greenway@grifols.com

Country

United Kingdom

NUTS code
  • UK - United Kingdom
National registration number

01456099

Internet address

www.grifols.com

The contractor/concessionaire is an SME

Yes

five.2.4) Information on value of the contract/lot/concession (at the time of conclusion of the contract;excluding VAT)

Total value of the procurement: £1

Section six. Complementary information

six.3) Additional information

The contract is for the benefit of the Authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers. The resulting product delivered against the contract may be made available to the UK devolved administrations, Crown Dependencies and British Overseas Territories to undertake their respective immunisation programmes.

six.4) Procedures for review

six.4.1) Review body

The High Court

Strand

London

WC2A 2LL

Email

generaloffice@administrativecourtoffice.justice.gov.uk

Country

United Kingdom

Internet address

https://www.gov.uk/courts-tribunals

Section seven: Modifications to the contract/concession

seven.1) Description of the procurement after the modifications

seven.1.1) Main CPV code

Immune sera and immunoglobulins

seven.1.3) Place of performance

NUTS code
  • UK - United Kingdom

seven.1.4) Description of the procurement:

Contract for the provision of Varicella-zoster immunoglobulin

seven.1.5) Duration of the contract, framework agreement, dynamic purchasing system or concession

Start date

1 May 2025

End date

30 April 2027

seven.1.6) Information on value of the contract/lot/concession (excluding VAT)

Total value of the contract/lot/concession:

£1

seven.1.7) Name and address of the contractor/concessionaire

Grifols UK Limited

3980 - 3990 Enterprise Cambridge Research Park Beach Drive Waterbeach Cambridgeshire

Cambridge

CB25 9PE

Email

christopher.greenway@grifols.com

Country

United Kingdom

NUTS code
  • UK - United Kingdom
National registration number

01456099

Internet address

www.grifols.com

The contractor/concessionaire is an SME

Yes

seven.2) Information about modifications

seven.2.1) Description of the modifications

Nature and extent of the modifications (with indication of possible earlier changes to the contract):

Increase in product volume.

seven.2.2) Reasons for modification

Need for additional works, services or supplies by the original contractor/concessionaire.

Description of the economic or technical reasons and the inconvenience or duplication of cost preventing a change of contractor:

The Authority is invoking the contractual flexibility provisions to authorise an increase in the product volume.

seven.2.3) Increase in price

Updated total contract value before the modifications (taking into account possible earlier contract modifications, price adaptions and average inflation)

Value excluding VAT: £1

Total contract value after the modifications

Value excluding VAT: £1

Get daily alerts for Find a Tender - Latest Notices

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from UKHSA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
UKHSA
Published
April 22nd, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Pharmaceutical companies Healthcare providers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Biological product procurement Immunisation supply
Geographic scope
United Kingdom GB

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Procurement
Topics
Public Health Government Contracting

Get alerts for this source

We'll email you when Find a Tender - Latest Notices publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!